ROTEM in Sepsis Trauma Outcome in Intensive Care

ConditionsSepsis - to Reduce Mortality in the Intensive Care Unit Trauma Coagulopathy

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorRegion Stockholm

About this trial

This prospective observational study aims to investigate the ability of advanced ROTEM analysis using Principal Component Analysis (PCA) to detect early signs of disseminated intravascular coagulation (DIC) and trauma-induced coagulopathy (TIC) in hospitalized patients with sepsis or trauma. Standard coagulation tests and ROTEM measurements will be collected and analyzed in relation to clinical outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

All patients in Stockhiolm Region

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

600 Participants

are grouped into 3 trial groups

Group A: Trauma

Group B: Sepsis

Group C: Control

Trial outcomes

Primary outcomes

Detection of abnormal coagulation clusters via PCA of ROTEM in trauma and sepsis patients

Time frame

Through study completion, an average of 2 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Region Stockholm

Lead sponsor

Source ClinicalTrials.gov

Apply now